Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00972816 · ClinicalTrials.gov registry record · Phase 2
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)
A Phase 2 study of Influenza, sponsored by Novartis Vaccines.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,357
- Enrollment target
- 20
- Study locations
NCT00972816 is a Phase 2 study of Influenza that has completed, run by Novartis Vaccines. The registered enrollment target is 1,357 participants, below the 36,795-participant average among 156 other Influenza trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT00972816, a Phase 2 study of Influenza, has completed, sponsored by Novartis Vaccines.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,357 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in healthy young children.
Conditions Studied
Interventions
- BIOLOGICAL MF59-eH1N1
Study Locations (20)
California
- Premier Health Research Center, LLC - Downey
- Madera Family Medical Group - Madera
- Center for Clincal Trials, LLC - Paramount
- Center for Clinical Trials, LLC - Paramount
- Center for Clinical Trials of San Gabriel - West Covina
Georgia
- Pediatrics and Adolescent Medicine - Marietta
- Pediatrics and Adolescent Medicine - Woodstock
Kansas
- Heartland Research Associates LLC - Arkansas City
- Heartland Research Associates LLC - Newton
Ohio
- Dr. Senders and Associates, Pediatrics - Cleveland
- Prestige Clinical Research - Franklin
Colorado
- 1st International Research Centers - Thornton
Illinois
- Northern Illinois Research Associates - DeKalb
Indiana
- Bluegrass Clinical Research, Inc. - New Albany
Kentucky
- Bluegrass Clinical Research, Inc (Brownsboro for drug shipment) - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,357 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00972816
The ClinicalTrials.gov registry entry for NCT00972816 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,357 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,795-participant average among 156 other Influenza trials with a reported enrollment target (96% lower). The listed sponsor is Novartis Vaccines, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which MF59-eH1N1 is the first listed.
NCT00972816 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Georgia, Kansas.
Frequently Asked Questions
What is clinical trial NCT00972816 about?
NCT00972816 is a clinical study titled "Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)". This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in healthy young children.
What is the current status of trial NCT00972816?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,357 participants. The study started on 2009-09. Estimated completion is 2010-10.
What conditions does trial NCT00972816 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT00972816?
The interventions under investigation include: MF59-eH1N1 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00972816?
This trial is sponsored by Novartis Vaccines, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00972816 being conducted?
This trial has 20 study locations across California, Colorado, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)
RECRUITING · Phase 2
-
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
RECRUITING · Phase 2
-
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
RECRUITING · Phase 2
-
Systems Investigation of Vaccine Responses in Aging and Frailty
RECRUITING · Phase 2
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
RECRUITING · Phase 2
-
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.